Header Ads

Italy back in lockdown. What happened?

Here is the latest news from the global pandemic.

Italy goes back to square one

Exactly one year after it became the first Western country to go into lockdown, Italy is shutting down schools and shops. Again.

In March 2020, in what then-Prime Minister Giuseppe Conte called the country's "darkest hour," the nation was ordered to stay at home. Schools, stores, parks and most industrial plants were closed, all public events were canceled and Italians were banned from traveling without a business or health-related justification for two months.

The drastic measures worked, and Italy's daily cases were cut in half. From early summer, people gradually got back to work, restaurants reopened and holidaymakers flocked to beaches.

Now, with infections at a three-month high and total deaths over 100,000, Mario Draghi's new government has imposed new travel restrictions and closed schools, restaurants and retail stores in most of the country. Production plants and essential businesses remain open, but the pervasive feeling among Italians is that the nation is back at square one.

So what went wrong?

The primary reason: a sluggish vaccine rollout. Italy has been behind the curve on vaccinations compared with countries like the U.K. and Israel, thanks to delivery delays by the main suppliers and poor coordination at the regional level. The problems couldn't have come at a worse time: The more-contagious U.K. strain is spreading across the nation.

A vaccine center in Rome earlier this month.

Photographer: Alessia Pierdomenico/Bloomberg

A few weeks ago, a military general was appointed to coordinate the government's action on the pandemic and focus on speeding up the inoculation campaign. Italy is currently administering about 170,000 doses a day. Draghi, a former European Central Bank head with a reputation for technocratic efficiency, has pledged to triple that.

To do so, the government will have to ensure that pharmaceutical companies step up vaccine deliveries, which have amounted to only about 8.9 million doses so far in a nation of more than 60 million. It will also need to improve local logistics. Until earlier this month, only about 70% of doses distributed had been used.

Another reason for the relapse is that after being isolated for two months last summer, Italians started traveling again domestically, allowing the virus to reach areas, mostly in the south, that were virtually untouched by the first wave of contagion. The latest travel restrictions are an attempt to make sure something like that doesn't happen again.—Flavia Rotondi

Track the vaccines

Are We Bending the Curve Yet?

Israel was first to show vaccinations having a nationwide effect. A separate analysis in the U.K. showed similar results. It's now a life-and-death contest between vaccine and virus. We've updated our vaccine tracker to allow you to explore vaccine rates vs Covid-19 cases in a number of countries. See the latest here.

Photographer: Kobi Wolf/Bloomberg

Photographer: Kobi Wolf/Bloomberg

Save the Date | Bloomberg New Economy Conversations with Andrew Browne: Big Pharma joined with governments to deliver vaccines in record time. The successful moonshot could spur future research into other affordable drugs. Join us March 23 at 10 a.m. EDT when Katalin Karikó, senior vice president of vaccine pioneer BioNTech, and others discuss Vaccine Miracles and the New Promise of Science. Register here.

What you should read

EU Travel-Pass Plan by June Seen as Tall Order
EU faces a tough task in to introduce Covid-19 passports by the summer.
There's a Covid Power Crisis. How Big Is It?
Millions of U.S. households have faced utility shutoffs for unpaid bills.
U.S. States Throw Open Vaccine Eligibility
A dozen U.S. states expand access to vaccinations earlier than planned.
New Zealand Mulls Limiting Mass Tourism 
"We cannot go back to the tourism model that existed prior to Covid-19."
Thailand to Reduce Quarantine for Visitors
Isolation period for tourists in the country cut to 10 days from April 1.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments